3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
5
Triple Negative Breast Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Camurati-Engelmann Syndrome
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Microsatellite Instability
1
Metastatic Solid Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pralsetinib
2
pembrolizumab
2
Brentuximab Vedotin
2
Bevacizumab
2
ribociclib
1
fosaprepitant
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Image-Guided
1
Plicamycin
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Genistein
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dexamethasone
1
Cisplatin
1
Carboplatin
1
Aprepitant
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Germ Cell and Embryonal
×
bintrafusp alfa protein, human
×
Clear all
No trials found.